Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-12-13 5:20 pm Sale | 13G | FINCH THERAPEUTICS GROUP INC FNCH | Ugwumba Chidozie | 160,366 9.99% | -3,339,634 (-95.42%) | View |
| 2022-02-14 3:59 pm Sale | 13G | FINCH THERAPEUTICS GROUP INC FNCH | Walton Thomas Layton | 0 0% | -3,487,168 (Position Closed) | View |
| 2022-02-14 3:46 pm Purchase | 13G | FINCH THERAPEUTICS GROUP INC FNCH | Ugwumba Chidozie | 3,500,000 7.37% | 3,500,000 (New Position) | View |
| 2021-04-01 5:22 pm Purchase | 13D | FINCH THERAPEUTICS GROUP INC FNCH | Crestovo Investor LLC | 12,641,441 26.8% | 12,641,441 (New Position) | View |
| 2021-03-29 4:41 pm Purchase | 13D | FINCH THERAPEUTICS GROUP INC FNCH | Haft Nicholas | 3,993,057 8.5% | 3,993,057 (New Position) | View |
| 2021-03-26 4:47 pm Purchase | 13G | FINCH THERAPEUTICS GROUP INC FNCH | Walton Thomas Layton | 3,487,168 7.4% | 3,487,168 (New Position) | View |